berberrubine has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abuduaini, N; Cui, J; Feng, B; He, X; Huang, J; Huang, Y; Lu, W; Ma, H; Tang, L; Wang, W; Wang, Y; Zhang, Y | 1 |
| Chung, IK; Kang, MR | 1 |
2 other study(ies) available for berberrubine and Colorectal Cancer
| Article | Year |
|---|---|
Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.
Topics: Animals; Berberine; Cell Line; Colorectal Neoplasms; Humans; IMP Dehydrogenase; Mice; Protein Isoforms | 2023 |
Down-regulation of DNA topoisomerase IIalpha in human colorectal carcinoma cells resistant to a protoberberine alkaloid, berberrubine.
Topics: Alkaloids; Antigens, Neoplasm; Antineoplastic Agents; Berberine; Colorectal Neoplasms; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Half-Life; Humans; Promoter Regions, Genetic; RNA, Messenger; Tumor Cells, Cultured | 2002 |